Literature DB >> 12407695

Cytogenetics and molecular genetics of cancer of the prostate.

Arthur R Brothman1.   

Abstract

Prostate cancer remains the most common male malignancy in Western countries and the second-leading cause of death from cancer in males. Progress in the understanding of molecular and genetic mechanisms leading to this disease has only recently begun to offer a glimpse of the genes, chromosomal sites, and proteins implicated in the development and progression of prostate tumors. This brief review addresses some of the key issues in prostate cancer research, including a discussion of both hereditary and sporadic cancers as well as specific genes and chromosomal loci that likely play a part in the etiology of this disease. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407695     DOI: 10.1002/ajmg.10694

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Authors:  Arnaldo A Arbini; Margherita Greco; Jorge L Yao; Patricia Bourne; Ersilia Marra; Jer-Tsong Hsieh; Paul A di Sant'agnese; Loredana Moro
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.

Authors:  Ashish B Rajput; Melinda A Miller; Alessandro De Luca; Niki Boyd; Sam Leung; Antonio Hurtado-Coll; Ladan Fazli; Edward C Jones; Jodie B Palmer; Martin E Gleave; Michael E Cox; David G Huntsman
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

3.  Upregulation of Cyclin B1 by miRNA and its implications in cancer.

Authors:  Vera Huang; Robert F Place; Victoria Portnoy; Ji Wang; Zhongxia Qi; Zhejun Jia; Angela Yu; Marc Shuman; Jingwei Yu; Long-Cheng Li
Journal:  Nucleic Acids Res       Date:  2011-11-03       Impact factor: 16.971

Review 4.  Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.

Authors:  Manny D Bacolod; Swadesh K Das; Upneet K Sokhi; Steven Bradley; David A Fenstermacher; Maurizio Pellecchia; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2015-05-23       Impact factor: 6.242

Review 5.  Genetic alteration and gene expression modulation during cancer progression.

Authors:  Cathie Garnis; Timon P H Buys; Wan L Lam
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.